Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2018/1329874 http://scihub22266oqcxt.onion/10.1155/2018/1329874 C6029447!6029447!30018818     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Ophthalmol 2018 ; 2018 (ä): ä Nephropedia Template TP {{tp|p=30018818|t=2018. Early Results with a New Posterior Chamber Phakic Intraocular Lens in Patients with High Myopia |pdf=|usr=}}{{30018818}} gab.com Text Early Results with a New Posterior Chamber Phakic Intraocular Lens in Patients with High Myopia JO: J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=30018818 #FOAvip Purpose: To report clinical results of a foldable, hydrophilic acrylic, single-piece, injectable, posterior chamber phakic intraocular lens (pIOL). Material and Methods: Medical records of patients who underwent posterior chamber phakic IOL (Eyecryl Phakic IOL, Biotech Vision Care, Ahmedabad, India) implantation for surgical correction of myopia were retrospectively reviewed. Only patients with at least a one-year follow-up were included. Manifest refraction, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), endothelial cell density (ECD), and pIOL vault were analyzed at 1, 3, 6, and 12 months after surgery. Complications observed during and after surgery were also recorded. Results: The study included 58 eyes of 29 patients. Mean patient age was 32?±?7 years. Spherical equivalent of manifest refraction was ?13.41?±?3.23?D preoperatively and ?0.44?±?0.55?D postoperatively. Preoperative CDVA was 0.29?±?0.71 logMAR. Postoperative UDVA and CDVA were 0.21?±?0.66 and 0.15?±?0.69 logMAR, respectively, at the 12-month visit. At the 12-month visit, the efficacy index was 1.20 and the safety index was 1.39. Mean ECD was 2713?±?339?cells/mm2 at the preoperative visit and 2608?±?362?cells/mm2 at the 12-month visit (3.9% loss, p < 0.001). ECD loss from 3 months to 12 months was not statistically significant. No significant cataract formation, significant endothelial cell loss, glaucoma, uveitis, or any other vision-threatening complication was observed. Conclusion: Based on postoperative experience, we have found that Eyecryl Phakic IOL is safe and effective for treating high myopia. Twit Text FOAVip Early Results with a New Posterior Chamber Phakic Intraocular Lens in Patients with High Myopia ????J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=30018818 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30018818 #FOAvip English Wikipedia <ref>{{Cite pmid|30018818}}</ref> Early Results with a New Posterior Chamber Phakic Intraocular Lens in Patients with High Myopia #MMPMID30018818 Ya?a D; Ürdem U; A?ca A; Yildirim Y; Kepez Yildiz B; Kandemir Be?ek N; Yi?it U; Demirok A J Ophthalmol 2018[]; 2018 (ä): ä PMID30018818show ga Purpose: To report clinical results of a foldable, hydrophilic acrylic, single-piece, injectable, posterior chamber phakic intraocular lens (pIOL). Material and Methods: Medical records of patients who underwent posterior chamber phakic IOL (Eyecryl Phakic IOL, Biotech Vision Care, Ahmedabad, India) implantation for surgical correction of myopia were retrospectively reviewed. Only patients with at least a one-year follow-up were included. Manifest refraction, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), endothelial cell density (ECD), and pIOL vault were analyzed at 1, 3, 6, and 12 months after surgery. Complications observed during and after surgery were also recorded. Results: The study included 58 eyes of 29 patients. Mean patient age was 32?±?7 years. Spherical equivalent of manifest refraction was ?13.41?±?3.23?D preoperatively and ?0.44?±?0.55?D postoperatively. Preoperative CDVA was 0.29?±?0.71 logMAR. Postoperative UDVA and CDVA were 0.21?±?0.66 and 0.15?±?0.69 logMAR, respectively, at the 12-month visit. At the 12-month visit, the efficacy index was 1.20 and the safety index was 1.39. Mean ECD was 2713?±?339?cells/mm2 at the preoperative visit and 2608?±?362?cells/mm2 at the 12-month visit (3.9% loss, p < 0.001). ECD loss from 3 months to 12 months was not statistically significant. No significant cataract formation, significant endothelial cell loss, glaucoma, uveitis, or any other vision-threatening complication was observed. Conclusion: Based on postoperative experience, we have found that Eyecryl Phakic IOL is safe and effective for treating high myopia. äEarly Results with a New Posterior Chamber Phakic Intraocular Lens in (epmc).pdf DeepDyve Pubget Overpricing